We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Cerep Announces the Extension of its Pharmaco-Informatics Alliance with Pfizer
News

Cerep Announces the Extension of its Pharmaco-Informatics Alliance with Pfizer

Cerep Announces the Extension of its Pharmaco-Informatics Alliance with Pfizer
News

Cerep Announces the Extension of its Pharmaco-Informatics Alliance with Pfizer

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Cerep Announces the Extension of its Pharmaco-Informatics Alliance with Pfizer"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Cerep has announces the extension of its pharmaco-informatics alliance with Pfizer for up to three years (through 2009).

Through this alliance, beginning in 2002, Pfizer has accessed Cerep’s BioPrint® data and the derived pharmaco-informatics methodologies. As part of the alliance, Pfizer and Cerep collaborate on the enhancement of BioPrint® and the derived pharmaco-informatic methods with Pfizer compounds. The goal of the collaboration is to provide early tools for in vitro safety evaluation of lead compounds.

"We are particularly happy to announce the extension of this alliance with Pfizer. We feel that the first four years of the collaboration have established and validated the use of the BioPrint® concept as a key technology to support decision-making.

We appreciate the effort that Pfizer has put into the alliance and we feel that the two companies, working together, can continue to make significant advances in the development and validation of predictive technologies", commented Thierry Jean, President & CEO, Cerep.

Advertisement